These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16838230)

  • 1. New drugs for Clostridium difficile infection.
    Bartlett JG
    Clin Infect Dis; 2006 Aug; 43(4):428-31. PubMed ID: 16838230
    [No Abstract]   [Full Text] [Related]  

  • 2. Bad bugs, no drugs: no ESCAPE revisited.
    Peterson LR
    Clin Infect Dis; 2009 Sep; 49(6):992-3. PubMed ID: 19694542
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clostridium difficile infections: an unexpected re-emergence].
    Barbut F
    Pathol Biol (Paris); 2008 Feb; 56(1):6-9. PubMed ID: 18178330
    [No Abstract]   [Full Text] [Related]  

  • 4. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection.
    Bartlett JG
    Clin Infect Dis; 2008 May; 46(10):1489-92. PubMed ID: 18419480
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotics and Clostridium difficile: cause and cure.
    Surawicz CM
    J Clin Gastroenterol; 2007 Jan; 41(1):1-2. PubMed ID: 17198057
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased effectiveness of metronidazole for the treatment of Clostridium difficile infection?
    Kuijper EJ; Wilcox MH
    Clin Infect Dis; 2008 Jul; 47(1):63-5. PubMed ID: 18491959
    [No Abstract]   [Full Text] [Related]  

  • 7. Reining in recurrent Clostridium difficile infection--who's at risk?
    Surawicz CM
    Gastroenterology; 2009 Apr; 136(4):1152-4. PubMed ID: 19250653
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment strategies for recurrent and refractory Clostridium difficile-associated diarrhea.
    Stepan C; Surawicz CM
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):295-305. PubMed ID: 19072422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fidaxomicin (Dificid) for Clostridium difficile infection.
    Med Lett Drugs Ther; 2011 Sep; 53(1373):73-4. PubMed ID: 21921871
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of first recurrences of Clostridium difficile-associated disease: waiting for new treatment options.
    Louie TJ
    Clin Infect Dis; 2006 Mar; 42(6):765-7. PubMed ID: 16477550
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances in Clostridium difficile-associated disease.
    Monaghan T; Boswell T; Mahida YR
    Postgrad Med J; 2009 Mar; 85(1001):152-62. PubMed ID: 19351643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collateral damage. The rise of resistant C. difficile.
    Taubes G
    Science; 2008 Jul; 321(5887):360. PubMed ID: 18635789
    [No Abstract]   [Full Text] [Related]  

  • 13. Clostridium difficile colitis: epidemiology, pathophysiology, and treatment.
    Mitty RD; Lamont JT
    Mt Sinai J Med; 1994 Sep; 61(4):329-35. PubMed ID: 7969226
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of clostridium difficile colitis in the critical care setting.
    Musher DM; Aslam S
    Crit Care Clin; 2008 Apr; 24(2):279-91, viii. PubMed ID: 18361946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Clostridium difficile-associated disease.
    Leffler DA; Lamont JT
    Gastroenterology; 2009 May; 136(6):1899-912. PubMed ID: 19457418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium difficile and fluoroquinolones: is there a link?
    Weiss K
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of the antimicrobial treatment of Clostridium difficile toxin-positive episodes using an integrated electronic prescribing, information and communication system.
    Jumaa P; Young I; Nightingale P; Clark I
    J Hosp Infect; 2009 Aug; 72(4):371-3. PubMed ID: 19592139
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection.
    Herpers BL; Vlaminckx B; Burkhardt O; Blom H; Biemond-Moeniralam HS; Hornef M; Welte T; Kuijper EJ
    Clin Infect Dis; 2009 Jun; 48(12):1732-5. PubMed ID: 19435431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of daptomycin compared to teicoplanin in the treatment of Clostridium difficile colitis in hamsters.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):209-10. PubMed ID: 16312372
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible role of cross-transmission between neonates and mothers with recurrent Clostridium difficile infections.
    McFarland LV; Surawicz CM; Greenberg RN; Bowen KE; Melcher SA; Mulligan ME
    Am J Infect Control; 1999 Jun; 27(3):301-3. PubMed ID: 10358237
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.